News

Almost 20 million Americans are affected by dry AMD and it is the leading cause of vision loss in the United States for adults over 60.

While researchers have known that AREDS 2 supplements help slow the progression of AMD from the intermediate stage to the late stage, they wanted to establish whether supplementation could impact t...

Despite it's hefty price tag, saffron, which is a powerful antioxidant, is a popular dietary supplement used for a wide range of ailments including the improvement of cognitive function, mood boost...

Minocycline, a commonly prescribed antibiotic that also offers anti-inflammatory effects, does not offer any benefits to those suffering from dry age-related macular degeneration.

More than one million Americans aged 40 and over are affected by geographic atrophy (otherwise known as advanced dry age-related macular degeneration), which currently has no available therapy that...

Geographic atrophy typically affects people over the age of 50 and is one of the main causes of vision loss in the United States.

Artificial intelligence may be the key in helping doctors determine which patients with intermediate AMD are at a high risk of the disease progressing to geographic atrophy.

Researchers hope that these cells are ready to be studied in human clinical trials 

Researchers examined data from 14 studies to determine the effect of drugs on the risk of developing AMD.